Equitable Allocation of COVID-19 Vaccine: Public Listening Session

Public Listening Session: Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine

On Wednesday, September 2, from 12:00 to 5:00 pm ET, the National Academies of Sciences, Engineering, and Medicine will host an open online session to receive public comments on a Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine, as part of a study sponsored by the National Institutes of Health and the Centers for Disease Control and Prevention. The study will recommend priorities to inform allocation of a limited initial supply of COVID-19 vaccine, taking into account factors such as racial/ethnic and other health disparities, as well as groups at higher risk from COVID-19 due to health status, occupation, or living conditions. Input from the public, especially communities highly impacted by COVID-19, is essential to produce a final report that is objective, balanced, and inclusive.

A discussion draft of the preliminary framework will be available for download starting 24 hours advance of the session, on Tuesday, September 1, at 12:00 pm ET. The draft can be accessed at nationalacademies.org/VaccineAllocationComment (link not live until 12:00 pm ET on 9/1/2020).

If you would like to make a comment on September 2, please complete our speaker sign-up form (in addition to this Eventbrite registration). Please note that, due to time constraints, we cannot guarantee that all of those who sign up to make comments will be confirmed to do so.

You will receive follow-up contact with further instructions dependent on whether or not you are confirmed to speak. You may make a comment as an individual or on behalf of an organization. All members of the public confirmed to speak will be given a specific time slot during the session and must limit their remarks to 5 minutes. Only those who receive a time slot and additional instructions from National Academies staff will be afforded time to speak. Due to the large volume of interested parties and limited time available, we cannot guarantee the opportunity to make oral comments for all those who sign up using the above form. Therefore, we encourage you to consider the written comment opportunity from September 1 to September 4 (more information below). Please contact COVIDVaccineFramework@nas.edu with questions.

You may also attend the September 2 session without making a comment. Simply register to attend using this Eventbrite registration and no further action is required.

Written Comment Period: September 1 (12:00 pm ET) - September 4, 2020 (11:59 pm ET)

Members of the public are encouraged to submit written comments for consideration by the study committee (as individuals or on behalf of an organization). The public comment period will be open for 4 days, from 12:00 p.m. ET on Tuesday, September 1, until 11:59 p.m. ET on Friday, September 4. Commenters will be able to download and review the discussion draft before submitting a comment through a form (uploaded documents accepted). All materials and comments received will be placed in the committee’s Public Access File, and may be provided to the public upon request. The discussion draft and comment form will be available at nationalacademies.org/VaccineAllocationComment starting at 12:00 pm ET on September 1.

For more information, please visit the study webpage.

Please note that events listed in the “Events You May Like” section may not be associated with or endorsed by the National Academies of Sciences, Engineering, and Medicine.